140 related articles for article (PubMed ID: 32150778)
1. Challenging diagnosis of two neoplasms, Langerhans cell histiocytosis and papillary thyroid carcinoma, from fine needle aspiration of the thyroid by cell-block immunocytochemistry and molecular testing for BRAF V600E mutation.
Zaidi A; Gautam U; Srinivasan R; Bal A; Prakash G; Sood A
Cytopathology; 2020 Nov; 31(6):598-601. PubMed ID: 32150778
[No Abstract] [Full Text] [Related]
2. BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review.
A Al Hamad M; Albisher HM; Al Saeed WR; Almumtin AT; Allabbad FM; A Shawarby M
BMC Cancer; 2019 Feb; 19(1):170. PubMed ID: 30795755
[TBL] [Abstract][Full Text] [Related]
3. Detection of BRAF V600E mutation in fine-needle aspiration fluid of papillary thyroid carcinoma by droplet digital PCR.
Xu X; Ma X; Zhang X; Cao G; Tang Y; Deng X; Kang Z; Li M; Guan M
Clin Chim Acta; 2019 Apr; 491():91-96. PubMed ID: 30682328
[TBL] [Abstract][Full Text] [Related]
4. A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration.
Dell'Aquila M; Gravina C; Cocomazzi A; Capodimonti S; Musarra T; Sfregola S; Fiorentino V; Revelli L; Martini M; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2019 Jun; 127(6):390-398. PubMed ID: 31135104
[TBL] [Abstract][Full Text] [Related]
5. Value of
Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
[TBL] [Abstract][Full Text] [Related]
6. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
Qi W; Shi C; Zhang P; Feng L; Wang J; Chen D
Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
[TBL] [Abstract][Full Text] [Related]
7. The Role of BRAF V600E in Reducing AUS/FLUS Diagnosis in Thyroid Fine Needle Aspiration.
Yin L; Tang Y; Yu S; Wang C; Xiao M; Wang Y; Liu SJ; Gao L; Huang K; Jin L
Endocr Pathol; 2019 Dec; 30(4):312-317. PubMed ID: 31529211
[TBL] [Abstract][Full Text] [Related]
8. The immunocytochemical expression of VE-1 (BRAF V600E-related) antibody identifies the aggressive variants of papillary thyroid carcinoma on liquid-based cytology.
Straccia P; Brunelli C; Rossi ED; Lanza P; Martini M; Musarra T; Lombardi CP; Pontecorvi A; Fadda G
Cytopathology; 2019 Sep; 30(5):460-467. PubMed ID: 30875124
[TBL] [Abstract][Full Text] [Related]
9. Critical Pitfalls in the use of BRAF Mutation as a Diagnostic Tool in Thyroid Nodules: a Case Report.
Kuhn E; Ragazzi M; Zini M; Giordano D; Nicoli D; Piana S
Endocr Pathol; 2016 Sep; 27(3):220-3. PubMed ID: 26782803
[TBL] [Abstract][Full Text] [Related]
10. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
Paek SH; Kim BS; Kang KH; Kim HS
World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392
[TBL] [Abstract][Full Text] [Related]
11. [Value of the detection of
Zhao H; Guo HQ; Zhang ZH; Cao J; Zhao LL; Sun Y; Wang C; Xiao T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):18-22. PubMed ID: 30704164
[No Abstract] [Full Text] [Related]
12. Papillary Thyroid Carcinoma BRAF Immunopositivity.
Erickson LA; Chen B
Mayo Clin Proc; 2021 Jan; 96(1):267-268. PubMed ID: 33413831
[No Abstract] [Full Text] [Related]
13. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K
Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
[TBL] [Abstract][Full Text] [Related]
14. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
15. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between Ultrasound-guided Fine-needle Aspiration Combined with BRAF
Zhang Y; Luo YK; Zhang Y; Zhang MB; Guang Y; Xie F; Jiang B; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):517-523. PubMed ID: 31484615
[TBL] [Abstract][Full Text] [Related]
17. One of the many faces of papillary thyroid carcinoma.
Stephen SN; Gochhait D; Ganesh RN; Ravi S; Siddaraju N
Cytopathology; 2020 Mar; 31(2):169-171. PubMed ID: 31509313
[No Abstract] [Full Text] [Related]
18. High-accuracy Detection of Preoperative Thyroid Nodules Using Combination of BRAF
Zhang Y; Zhang Z; Ma J; Pu J; Hou P; Yang Q
Arch Med Res; 2018 Aug; 49(6):365-372. PubMed ID: 30518486
[TBL] [Abstract][Full Text] [Related]
19. Detection of BRAF V600E Mutations With Next-Generation Sequencing in Infarcted Thyroid Carcinomas After Fine-Needle Aspiration.
Kouba E; Ford A; Brown CG; Yeh C; Siegal GP; Manne U; Eltoum IE
Am J Clin Pathol; 2018 Jul; 150(2):177-185. PubMed ID: 29868707
[TBL] [Abstract][Full Text] [Related]
20. BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas.
Lee JI; Jang HW; Kim SW; Kim JW; Oh YL; Chung JH
Head Neck; 2013 Apr; 35(4):548-53. PubMed ID: 22488961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
